Validea's guru fundamental report indicates that LAM RESEARCH CORP (LRCX) receives a 100% rating based on their Patient Investor model, which is based on the investment strategy of Warren Buffett. The analysis highlights LRCX's strong underlying fundamentals and reasonable valuation as key factors, as it passes all of the model's tests including earnings predictability, debt service, return on equity, and free cash flow.
Lam Research Corp (LRCX), a large-cap growth stock within the Semiconductors industry, has achieved a perfect 100% rating according to Validea's Patient Investor model, which emulates the investment strategy of Warren Buffett. This top score signifies strong interest from the model, predicated on LRCX's robust underlying fundamentals and what the strategy considers a reasonable valuation. The company successfully passed all nine criteria evaluated by this model: earnings predictability, debt service capacity, return on equity, return on total capital, free cash flow generation, effective use of retained earnings, share repurchase activity, initial rate of return, and expected future return. This comprehensive endorsement highlights LRCX's alignment with principles favoring long-term, predictable profitability and low financial leverage, as indicated by the strongly positive sentiment score of 0.9 specifically for LRCX.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment
